Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06736496Phase 4Not yet recruiting
Phase 4, randomised trial of dexmedetomidine in gallbladder disease (2 arms), sponsored by Assiut University. Primary endpoint: Amount of Opioid Consumption at 24 hours. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06736496.